Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_06-cv-00627/USCOURTS-cand-3_06-cv-00627-0/pdf.json

Parties Involved:
AstraZeneca Pharmaceuticals, L.P.
Defendant
AstraZeneca, L.P.
Defendant
Dianne Mack
Plaintiff

Document Text:

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

For the Northern District of California

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

DIANNE MACK,

Plaintiff,

 v.

ASTRAZENECA PHARMACEUTICALS, L.P.

and ASTRAZENECA, L.P.,

Defendants.

 /

No. C-06-0627 MMC

ORDER CONTINUING CASE

MANAGEMENT CONFERENCE

Before the Court is plaintiff’s Case Management Conference Statement, filed May 2,

2006, by which plaintiff seeks to continue the May 12, 2006 case management conference

in the instant action by approximately 120 days. Plaintiff states a continuance is necessary

because she anticipates the instant action will be transferred for inclusion in MDL No. 1769,

In re Seroquel Products Liability Litigation, and because she has not yet served the

defendants. Because the instant action was filed January 30, 2006, the 120-day deadline

for plaintiff to serve defendants, pursuant to Rule 4(m) of the Federal Rules of Civil

Procedure, has not yet elapsed.

Accordingly, for good cause shown,

1. The May 12, 2006 case management conference is hereby continued to

Case 3:06-cv-00627-MMC Document 6 Filed 05/02/06 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

2

September 8, 2006 at 10:30 a.m. A joint case management statement shall be filed no

later than September 1, 2006. The deadline to serve the defendants, pursuant to Rule

4(m) of the Federal Rules of Civil Procedure, remains in effect.

IT IS SO ORDERED.

Dated: May 2, 2006 MAXINE M. CHESNEY

United States District Judge

Case 3:06-cv-00627-MMC Document 6 Filed 05/02/06 Page 2 of 2